Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 127 consecutive patients from a single Japanese institution

Author:

Kagami Satoru1,Funahashi Kimihiko1,Koda Takamaru1,Ushigome Toshimitsu1,Kaneko Tomoaki1,Suzuki Takayuki1,Miura Yasuyuki1,Nagashima Yasuo1,Yoshida Kimihiko1,Kurihara Akiharu1

Affiliation:

1. Toho University Omori Medical Center

Abstract

Abstract Purpose In laparoscopic sphincter-preserving surgery (lap-SPS) for rectal cancer (RC), total mesorectal excision (TME) in low RC patients is difficult. This study aimed to evaluate the short- and long-term outcomes of transanal down-to-up dissection of the distal rectum to achieve TME in lap-SPS for RC near the anus. Methods A total of 137 consecutive patients with RC near the anus underwent lap-SPS, with either transanal rectal dissection under direct vision (TARD), which mobilized the most difficult portion of TME via the anus, or trans-anal TME (TaTME), which used an endoscopic system, between January 2006 and February 2021. Results A total of 127 consecutive patients (87 men), with a median age of 66 years (range: 33–86 years), were included. TARD and TaTME were performed in 51 (40.2%) and 76 (59.8%) patients, respectively. Preoperative treatment was performed in 41 (32.3%) patients. Although operative time in the transanal portion in the TaTME group was longer (p < 0.001), total operative time was unaffected. Median blood loss was lower in the TaTME group (p < 0.001). Postoperative complications developed in 56 (44.1%) patients. TME quality was good for almost all the patients and recurrence occurred in 18 patients (14.2%). The five-year overall survival and disease-free survival rates in the 127 patients were 90.4% and 83.2%, respectively. Conclusion Our data suggest that a transanal down-to-up dissection of the distal rectum might be a viable approach in lap-SPS for RC near the anus. Further studies are needed to examine the differences between TARD and TaTME.

Publisher

Research Square Platform LLC

Reference41 articles.

1. 1. van der Pas MH, Haglind E, Cuesta MA, Fürst A, Lacy AM, Hop WC, Bonjer HJ, COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218. https://doi.org/10.1016/S1470-2045(13)70016-0

2. 2. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, ALaCaRT Investigators (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314(13):1356–1363. https://doi.org/10.1001/jama.2015.12009

3. 3. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of Stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355. https://doi.org/10.1001/jama.2015.10529

4. 4. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES, Lacy AM, Bemelman WA, Andersson J, Angenete E, Rosenberg J, Fuerst A, Haglind E, COLOR II Study Group (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372(14):1324–1332. https://doi.org/10.1056/NEJMoa1414882

5. 5. Stevenson ARL, Solomon MJ, Brown CSB, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Wilson K, Hague W, Simes J, Australasian Gastro-Intestinal Trials Group (AGITG) (2019) ALaCaRT investigators. Disease-free Survival and local Recurrence After Laparoscopic-assisted Resection or open Resection for rectal Cancer: the Australasian laparoscopic Cancer of the rectum Randomized. Clinical Trial Ann Surg 269(4):596–602. https://doi.org/10.1097/SLA.0000000000003021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3